Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor Progression
100%
Breast Carcinoma
100%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
100%
Effusion
100%
Mitogen-activated Protein Kinase
55%
JNK1
55%
P-p38
55%
Apoptosis
33%
Overall Survival
33%
Ki-67
33%
Immunoblotting
33%
P38 Activation
22%
Activation Ratio
22%
Prognostic Marker
11%
Clinical Parameters
11%
Metastasis
11%
Primary Tumor
11%
Chemotherapy
11%
Immunohistochemistry
11%
Survival Analysis
11%
Solid Tumors
11%
Survival Benefit
11%
Lymph Node Metastasis
11%
Activity Ratio
11%
Stress-related
11%
Hormone Receptor-positive
11%
Previous Chemotherapy
11%
In Vivo Activity
11%
Nuclear Expression
11%
JNK Activation
11%
Breast Carcinoma Cells
11%
Prognosticator
11%
Patients with Breast Cancer
11%
Site Parameters
11%
ER Status
11%
HER2 Status
11%
Anatomic Site
11%
Advanced Disease Stages
11%
Cox multivariate Analysis
11%
Medicine and Dentistry
Tumor Progression
100%
Breast Carcinoma
100%
Effusion
100%
Mitogen Activated Protein Kinase P38
100%
Mitogen-Activated Protein Kinase
55%
Overall Survival
33%
Programmed Cell Death
33%
Immunoblotting
33%
Proportional Hazards Model
11%
Metastatic Carcinoma
11%
Breast Cancer
11%
Primary Tumor
11%
Immunohistochemistry
11%
Hormone Receptor
11%
Solid Malignant Neoplasm
11%
Lymph Node Metastasis
11%
Survival Analysis
11%
Drive
11%
Carcinoma Cell
11%
Patient History of Chemotherapy
11%
Poly ADP Ribose Polymerase
11%
Diseases
11%
Chemotherapy
11%